Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma (Q44653322)
Jump to navigation
Jump to search
scientific article published on November 1, 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma |
scientific article published on November 1, 2003 |
Statements
Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma (English)
Marco Scarsella
Lucio Tentori
Carlo Leonetti
Giulia D'Amati
Matteo Vergati
Ilaria Portarena
Weizheng Xu
Vincent Kalish
Gabriella Zupi
Jie Zhang
Grazia Graziani
1 November 2003